|Company name||Acacia Research Corporation|
|Live stock price||[stckqut]ACTG[/stckqut]|
|P/E compared to competitors||Fair|
|Confident Investor Rating||Poor|
|Target stock price (TWCA growth scenario)||$0|
|Target stock price (averages with growth)||$0.13|
|Target stock price (averages with no growth)||$0.51|
|Target stock price (manual assumptions)||$19|
The following company description is from Google Finance: http://www.google.com/finance?q=actg
Acacia Research Corporation, through its operating subsidiaries, acquires, develops, licenses and enforces patented technologies. Its operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies. In November 2011, it announced that a subsidiary had acquired rights to semiconductor memory and process patents from a technology company. In November 2011, it announced that a subsidiary has acquired six portfolios relating to cellular technology, mobile handsets, wireless local area networks, video processing, Internet Protocol Television technology, and location based services technology. In December 2011, the Company announced that a subsidiary acquired patents for inhaler drug delivery technology from a major medical company.
Confident Investor comments: At this price and at this time, I do not think that a Confident Investor can confidently invest in this stock. This is the kind of company that I invariably will get emails about that I don’t understand how great this company is. They will be right – there is a lot to not like about this company. I consider this to be a relatively risky investment but for those of you that like a risky investment, I will not stop you. In addition to not liking the fundamentals, I also don’t like the business that this company is in.